Feature|Videos|October 21, 2025
When Did the FDA Begin Regulating UVC Devices in Healthcare Environments?
Advertisement
Episodes in this series
Hospitals are embracing whole-room microbial reduction as a backstop to inconsistent surface cleaning, and the FDA has now created a formal regulatory pathway that finally defines what compliance and validated claims look like. That clarity raises new questions for infection prevention and environmental services teams about procurement, risk management, and how these tools fit into patient-safety strategies. In this section, our panelists explain how we got here and what the new oversight means for real-world adoption and outcomes.
Advertisement
Related to this article
AI tools may help clinicians recognize sepsis earlier, but false alarms, limited external validation, and uncertain effects on patient outcomes complicate their use in adult and neonatal intensive care.
An imported case of Bundibugyo virus disease in Kenya raises questions about airport screening, clinical recognition, and potential exposures, highlighting the importance of coordinated contact tracing and hospital infection prevention readiness.
Florida’s dengue outbreak highlights the importance of recognizing symptoms, identifying warning signs, and preventing mosquito bites. Ubong Johnson, MD, explains local transmission, diagnostic testing, treatment, and practical prevention measures.
Understanding current water quality is a starting point for ST108 implementation. John Kimsey, vice president of processing optimization and customer success for STERIS, spoke about his HSPA presentation on assessing readiness, distinguishing system qualification from routine testing, and understanding where water samples should be collected.
An unexplained death at a Russian plague research institute has prompted international scrutiny. The incident raises questions about laboratory safety, transparent reporting, and infection prevention preparedness while the cause remains unconfirmed.
Behind every landmark in infection prevention, from antimicrobial stewardship guidelines to the COVID-19 town halls that reached flight attendants and teachers, is a generation of physician-scientists who led SHEA through crises, organizational change, and scientific breakthroughs. Infection Control Today traces 30 years of SHEA presidents and the lasting mark they left on the field.
Missing instruments and processing delays can strain OR–SPD relationships. At AORN 2026, John Kimsey, vice president of processing optimization and customer success for STERIS, discusses understanding root causes, exploring off-site reprocessing for ambulatory surgical centers, and using hands-on simulation to help surgical teams see sterile processing from a different perspective.
This week's coverage in Infection Control Today centered on a common thread: the systems, partnerships, and data that let infection prevention teams catch problems before patients are harmed.
Advertisement
Advertisement